关于基本的FcRn机制与抗体的目标介导排放之间的合
Csaba B Kátai1, Manon M M Berns2, Jeroen Elassaiss-Schaap2
1PD-value B.V., Jansdam 2a, Utrecht, 3512 HB, The Netherlands. csaba@pd-value.com.
Journal of pharmacokinetics and pharmacodynamics
|November 27, 2025
概括
这项研究将新生儿Fc受体 (FcRn) 循环和向中介药物排放 (TMDD) 整合到一个单一的药理学模型中. 它提供了对抗体清除的分析见解,并指导了未来的建模工作.
科学领域:
- 药理动力学 药理动力学
- 生物制药科学 生物制药科学
- 计算生物学 计算生物学
背景情况:
- 抗体的药理动力学受到新生儿Fc受体 (FcRn) 循环和向中介药物排放 (TMDD) 的控制.
- 对FcRn和TMDD的单独分析已经存在,但它们的综合效应和特征时间尺度仍未得到充分研究.
- 整合这些机制对于准确的抗体配置建模至关重要.
研究的目的:
- 开发一个统一的药理动力学模型,将FcRn介导的救援和治疗抗体的TMDD结合起来.
- 分析特异性 (TMDD) 和非特异性 (FcRn) 清除机制之间的相互作用.
- 为了获得关键的药理动力学参数的分析表达式,并评估模型假设.
主要方法:
- 开发了一个基于最小生理学的药理动力学模型,其中包括FcRn和TMDD.
- 利用了在高结合亲和度极限中匹配的非对称扩张的方法.
- 研究了两个参数制度,其中FcRn和TMDD的贡献是可比的.
主要成果:
- 组合模型阐明了不同时间尺度上的抗体药理动力学.
- 对于受体和,AUC和终端斜率的衍生药量表达式.
- 确定了特定药理动力学阶段的主导清除过程和参数.
结论:
- 集成的FcRn-TMDD模型为了解合抗体清除机制提供了一个框架.
- 获得的分析见解可以指导在药理动力学研究中的参数估计和模型验证.
- 这种方法增强了治疗抗体的基于生理学和标准的药理动力学建模.
相关概念视频
Antibody Actions
2.2K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.2K
Affinity and Avidity
38.3K
Overview
38.3K
Drug Distribution: Plasma Protein Binding
8.2K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.2K
Humoral Immune Responses
83.1K
Overview
83.1K
Diversity of Antigen Receptors
1.3K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.3K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K


